Cinctive Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$340K	Buy	+24,310	New	+$340K	0.02%	321
2025 Q1	–	Sell	-130,445	Closed	-$2.66M	–	344
2024 Q4	$2.66M	Sell	130,445 -18,649	-13%	-$380K	0.14%	185
2024 Q3	$4.34M	Buy	149,094 +36,771	+33%	+$1.07M	0.24%	133
2024 Q2	$2.61M	Buy	+112,323	New	+$2.61M	0.12%	203